ARTICLE | Clinical News
Zorbtive somatropin recombinant human growth hormone regulatory update
December 8, 2003 8:00 AM UTC
The FDA granted marketing approval for Zorbtive to treat short bowel syndrome from SEO. Earlier this year, the FDA granted marketing approval for Serostim (Zorbtive) to treat HIV wasting or cachexia....